Clinical profile of arrhythmogenic right ventricular cardiomyopathy in Chinese patients

W H Fung1, J E Sanderson

  • 1Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.

Insights

Arrhythmogenic right ventricular cardiomyopathy (ARVC) in Chinese patients presents with palpitations and dizziness. Magnetic resonance imaging (MRI) is the preferred diagnostic tool, with low familial incidence of sudden death observed.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Imaging

Background:

  • Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic heart muscle disease.
  • It primarily affects the right ventricle, leading to arrhythmias and sudden cardiac death.
  • Understanding the clinical profile in diverse populations is crucial for diagnosis and management.

Purpose of the Study:

  • To delineate the clinical characteristics of Chinese patients diagnosed with arrhythmogenic right ventricular cardiomyopathy (ARVC).
  • To evaluate the diagnostic utility of various imaging modalities, particularly MRI, in this cohort.
  • To assess the incidence of familial sudden cardiac death and left ventricular involvement in Chinese ARVC patients.

Main Methods:

  • Retrospective analysis of clinical data from Chinese patients meeting established ARVC diagnostic criteria.
  • Inclusion of data from electrocardiography (ECG), echocardiography, cardiac catheterization, MRI, and electrophysiology studies (EPS).
  • Assessment of presenting symptoms, family history, and therapeutic interventions.

Main Results:

  • Eleven Chinese patients (7 male, mean age 42.6 years) were diagnosed with ARVC.
  • Common symptoms included palpitations (73%) and dizziness (46%); 54% presented with ventricular tachycardia.
  • MRI revealed RV abnormalities in 90%, while familial sudden death incidence was low (18.1%).

Conclusions:

  • Familial incidence of premature sudden death and left ventricular involvement are uncommon in Chinese ARVC patients.
  • Magnetic resonance imaging (MRI) is highly effective for diagnosing ARVC in this population.
  • Palpitations and dizziness are frequent presenting symptoms, with ventricular tachycardia being a common arrhythmia.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...